Felis catus (domestic cat): 101087614
Help
Entry
101087614 CDS
T02385
Symbol
MAPK1
Name
(RefSeq) mitogen-activated protein kinase 1
KO
K04371
mitogen-activated protein kinase 1/3 [EC:
2.7.11.24
]
Organism
fca
Felis catus (domestic cat)
Pathway
fca01521
EGFR tyrosine kinase inhibitor resistance
fca01522
Endocrine resistance
fca01524
Platinum drug resistance
fca04010
MAPK signaling pathway
fca04012
ErbB signaling pathway
fca04014
Ras signaling pathway
fca04015
Rap1 signaling pathway
fca04022
cGMP-PKG signaling pathway
fca04024
cAMP signaling pathway
fca04062
Chemokine signaling pathway
fca04066
HIF-1 signaling pathway
fca04068
FoxO signaling pathway
fca04071
Sphingolipid signaling pathway
fca04072
Phospholipase D signaling pathway
fca04114
Oocyte meiosis
fca04140
Autophagy - animal
fca04148
Efferocytosis
fca04150
mTOR signaling pathway
fca04151
PI3K-Akt signaling pathway
fca04210
Apoptosis
fca04218
Cellular senescence
fca04261
Adrenergic signaling in cardiomyocytes
fca04270
Vascular smooth muscle contraction
fca04350
TGF-beta signaling pathway
fca04360
Axon guidance
fca04370
VEGF signaling pathway
fca04371
Apelin signaling pathway
fca04380
Osteoclast differentiation
fca04510
Focal adhesion
fca04520
Adherens junction
fca04540
Gap junction
fca04550
Signaling pathways regulating pluripotency of stem cells
fca04611
Platelet activation
fca04613
Neutrophil extracellular trap formation
fca04620
Toll-like receptor signaling pathway
fca04621
NOD-like receptor signaling pathway
fca04625
C-type lectin receptor signaling pathway
fca04650
Natural killer cell mediated cytotoxicity
fca04657
IL-17 signaling pathway
fca04658
Th1 and Th2 cell differentiation
fca04659
Th17 cell differentiation
fca04660
T cell receptor signaling pathway
fca04662
B cell receptor signaling pathway
fca04664
Fc epsilon RI signaling pathway
fca04666
Fc gamma R-mediated phagocytosis
fca04668
TNF signaling pathway
fca04713
Circadian entrainment
fca04720
Long-term potentiation
fca04722
Neurotrophin signaling pathway
fca04723
Retrograde endocannabinoid signaling
fca04724
Glutamatergic synapse
fca04725
Cholinergic synapse
fca04726
Serotonergic synapse
fca04730
Long-term depression
fca04810
Regulation of actin cytoskeleton
fca04910
Insulin signaling pathway
fca04912
GnRH signaling pathway
fca04914
Progesterone-mediated oocyte maturation
fca04915
Estrogen signaling pathway
fca04916
Melanogenesis
fca04917
Prolactin signaling pathway
fca04919
Thyroid hormone signaling pathway
fca04921
Oxytocin signaling pathway
fca04926
Relaxin signaling pathway
fca04928
Parathyroid hormone synthesis, secretion and action
fca04929
GnRH secretion
fca04930
Type II diabetes mellitus
fca04933
AGE-RAGE signaling pathway in diabetic complications
fca04934
Cushing syndrome
fca04935
Growth hormone synthesis, secretion and action
fca04960
Aldosterone-regulated sodium reabsorption
fca05010
Alzheimer disease
fca05020
Prion disease
fca05022
Pathways of neurodegeneration - multiple diseases
fca05034
Alcoholism
fca05132
Salmonella infection
fca05133
Pertussis
fca05135
Yersinia infection
fca05140
Leishmaniasis
fca05142
Chagas disease
fca05145
Toxoplasmosis
fca05152
Tuberculosis
fca05160
Hepatitis C
fca05161
Hepatitis B
fca05163
Human cytomegalovirus infection
fca05164
Influenza A
fca05165
Human papillomavirus infection
fca05166
Human T-cell leukemia virus 1 infection
fca05167
Kaposi sarcoma-associated herpesvirus infection
fca05170
Human immunodeficiency virus 1 infection
fca05171
Coronavirus disease - COVID-19
fca05200
Pathways in cancer
fca05203
Viral carcinogenesis
fca05205
Proteoglycans in cancer
fca05206
MicroRNAs in cancer
fca05207
Chemical carcinogenesis - receptor activation
fca05208
Chemical carcinogenesis - reactive oxygen species
fca05210
Colorectal cancer
fca05211
Renal cell carcinoma
fca05212
Pancreatic cancer
fca05213
Endometrial cancer
fca05214
Glioma
fca05215
Prostate cancer
fca05216
Thyroid cancer
fca05218
Melanoma
fca05219
Bladder cancer
fca05220
Chronic myeloid leukemia
fca05221
Acute myeloid leukemia
fca05223
Non-small cell lung cancer
fca05224
Breast cancer
fca05225
Hepatocellular carcinoma
fca05226
Gastric cancer
fca05230
Central carbon metabolism in cancer
fca05231
Choline metabolism in cancer
fca05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
fca05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
fca00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
101087614 (MAPK1)
04012 ErbB signaling pathway
101087614 (MAPK1)
04014 Ras signaling pathway
101087614 (MAPK1)
04015 Rap1 signaling pathway
101087614 (MAPK1)
04350 TGF-beta signaling pathway
101087614 (MAPK1)
04370 VEGF signaling pathway
101087614 (MAPK1)
04371 Apelin signaling pathway
101087614 (MAPK1)
04668 TNF signaling pathway
101087614 (MAPK1)
04066 HIF-1 signaling pathway
101087614 (MAPK1)
04068 FoxO signaling pathway
101087614 (MAPK1)
04072 Phospholipase D signaling pathway
101087614 (MAPK1)
04071 Sphingolipid signaling pathway
101087614 (MAPK1)
04024 cAMP signaling pathway
101087614 (MAPK1)
04022 cGMP-PKG signaling pathway
101087614 (MAPK1)
04151 PI3K-Akt signaling pathway
101087614 (MAPK1)
04150 mTOR signaling pathway
101087614 (MAPK1)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
101087614 (MAPK1)
04148 Efferocytosis
101087614 (MAPK1)
09143 Cell growth and death
04114 Oocyte meiosis
101087614 (MAPK1)
04210 Apoptosis
101087614 (MAPK1)
04218 Cellular senescence
101087614 (MAPK1)
09144 Cellular community - eukaryotes
04510 Focal adhesion
101087614 (MAPK1)
04520 Adherens junction
101087614 (MAPK1)
04540 Gap junction
101087614 (MAPK1)
04550 Signaling pathways regulating pluripotency of stem cells
101087614 (MAPK1)
09142 Cell motility
04810 Regulation of actin cytoskeleton
101087614 (MAPK1)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
101087614 (MAPK1)
04613 Neutrophil extracellular trap formation
101087614 (MAPK1)
04620 Toll-like receptor signaling pathway
101087614 (MAPK1)
04621 NOD-like receptor signaling pathway
101087614 (MAPK1)
04625 C-type lectin receptor signaling pathway
101087614 (MAPK1)
04650 Natural killer cell mediated cytotoxicity
101087614 (MAPK1)
04660 T cell receptor signaling pathway
101087614 (MAPK1)
04658 Th1 and Th2 cell differentiation
101087614 (MAPK1)
04659 Th17 cell differentiation
101087614 (MAPK1)
04657 IL-17 signaling pathway
101087614 (MAPK1)
04662 B cell receptor signaling pathway
101087614 (MAPK1)
04664 Fc epsilon RI signaling pathway
101087614 (MAPK1)
04666 Fc gamma R-mediated phagocytosis
101087614 (MAPK1)
04062 Chemokine signaling pathway
101087614 (MAPK1)
09152 Endocrine system
04910 Insulin signaling pathway
101087614 (MAPK1)
04929 GnRH secretion
101087614 (MAPK1)
04912 GnRH signaling pathway
101087614 (MAPK1)
04915 Estrogen signaling pathway
101087614 (MAPK1)
04914 Progesterone-mediated oocyte maturation
101087614 (MAPK1)
04917 Prolactin signaling pathway
101087614 (MAPK1)
04921 Oxytocin signaling pathway
101087614 (MAPK1)
04926 Relaxin signaling pathway
101087614 (MAPK1)
04935 Growth hormone synthesis, secretion and action
101087614 (MAPK1)
04919 Thyroid hormone signaling pathway
101087614 (MAPK1)
04928 Parathyroid hormone synthesis, secretion and action
101087614 (MAPK1)
04916 Melanogenesis
101087614 (MAPK1)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
101087614 (MAPK1)
04270 Vascular smooth muscle contraction
101087614 (MAPK1)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
101087614 (MAPK1)
09156 Nervous system
04724 Glutamatergic synapse
101087614 (MAPK1)
04725 Cholinergic synapse
101087614 (MAPK1)
04726 Serotonergic synapse
101087614 (MAPK1)
04720 Long-term potentiation
101087614 (MAPK1)
04730 Long-term depression
101087614 (MAPK1)
04723 Retrograde endocannabinoid signaling
101087614 (MAPK1)
04722 Neurotrophin signaling pathway
101087614 (MAPK1)
09158 Development and regeneration
04360 Axon guidance
101087614 (MAPK1)
04380 Osteoclast differentiation
101087614 (MAPK1)
09159 Environmental adaptation
04713 Circadian entrainment
101087614 (MAPK1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
101087614 (MAPK1)
05206 MicroRNAs in cancer
101087614 (MAPK1)
05205 Proteoglycans in cancer
101087614 (MAPK1)
05207 Chemical carcinogenesis - receptor activation
101087614 (MAPK1)
05208 Chemical carcinogenesis - reactive oxygen species
101087614 (MAPK1)
05203 Viral carcinogenesis
101087614 (MAPK1)
05230 Central carbon metabolism in cancer
101087614 (MAPK1)
05231 Choline metabolism in cancer
101087614 (MAPK1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
101087614 (MAPK1)
09162 Cancer: specific types
05210 Colorectal cancer
101087614 (MAPK1)
05212 Pancreatic cancer
101087614 (MAPK1)
05225 Hepatocellular carcinoma
101087614 (MAPK1)
05226 Gastric cancer
101087614 (MAPK1)
05214 Glioma
101087614 (MAPK1)
05216 Thyroid cancer
101087614 (MAPK1)
05221 Acute myeloid leukemia
101087614 (MAPK1)
05220 Chronic myeloid leukemia
101087614 (MAPK1)
05218 Melanoma
101087614 (MAPK1)
05211 Renal cell carcinoma
101087614 (MAPK1)
05219 Bladder cancer
101087614 (MAPK1)
05215 Prostate cancer
101087614 (MAPK1)
05213 Endometrial cancer
101087614 (MAPK1)
05224 Breast cancer
101087614 (MAPK1)
05223 Non-small cell lung cancer
101087614 (MAPK1)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
101087614 (MAPK1)
05170 Human immunodeficiency virus 1 infection
101087614 (MAPK1)
05161 Hepatitis B
101087614 (MAPK1)
05160 Hepatitis C
101087614 (MAPK1)
05171 Coronavirus disease - COVID-19
101087614 (MAPK1)
05164 Influenza A
101087614 (MAPK1)
05163 Human cytomegalovirus infection
101087614 (MAPK1)
05167 Kaposi sarcoma-associated herpesvirus infection
101087614 (MAPK1)
05165 Human papillomavirus infection
101087614 (MAPK1)
09171 Infectious disease: bacterial
05132 Salmonella infection
101087614 (MAPK1)
05135 Yersinia infection
101087614 (MAPK1)
05133 Pertussis
101087614 (MAPK1)
05152 Tuberculosis
101087614 (MAPK1)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
101087614 (MAPK1)
05140 Leishmaniasis
101087614 (MAPK1)
05142 Chagas disease
101087614 (MAPK1)
09164 Neurodegenerative disease
05010 Alzheimer disease
101087614 (MAPK1)
05020 Prion disease
101087614 (MAPK1)
05022 Pathways of neurodegeneration - multiple diseases
101087614 (MAPK1)
09165 Substance dependence
05034 Alcoholism
101087614 (MAPK1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
101087614 (MAPK1)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
101087614 (MAPK1)
04933 AGE-RAGE signaling pathway in diabetic complications
101087614 (MAPK1)
04934 Cushing syndrome
101087614 (MAPK1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
101087614 (MAPK1)
01524 Platinum drug resistance
101087614 (MAPK1)
01522 Endocrine resistance
101087614 (MAPK1)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
fca01001
]
101087614 (MAPK1)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:
fca03036
]
101087614 (MAPK1)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:
fca04147
]
101087614 (MAPK1)
Enzymes [BR:
fca01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
101087614 (MAPK1)
Protein kinases [BR:
fca01001
]
Serine/threonine kinases: CMGC group
MAPK family [OT]
101087614 (MAPK1)
Chromosome and associated proteins [BR:
fca03036
]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
101087614 (MAPK1)
Exosome [BR:
fca04147
]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
101087614 (MAPK1)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
ABC1
APH
Haspin_kinase
Choline_kinase
FTA2
Kdo
Motif
Other DBs
NCBI-GeneID:
101087614
NCBI-ProteinID:
XP_003995022
Ensembl:
ENSFCAG00000002630
LinkDB
All DBs
Position
D3:complement(29458187..29565208)
Genome browser
AA seq
360 aa
AA seq
DB search
MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE
HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQH
LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH
TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI
LGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHK
RIEVEQALAHPYLEQYYDPSDEPVAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS
NT seq
1083 nt
NT seq
+upstream
nt +downstream
nt
atggcggcggcggcggcggcgggcgcgggcccggagatggtccgcgggcaggtgttcgac
gtggggccgcgctacaccaacctctcgtatatcggcgagggcgcctacggcatggtgtgc
tctgcttatgataatgtcaacaaagttcgagtagctatcaagaaaatcagtccttttgag
caccagacctactgccagagaaccctgagggagataaaaatcttactgcgcttcagacat
gagaacatcattggaatcaatgatattattagagcgccaaccatcgagcaaatgaaagat
gtatatatagtacaggacctcatggaaacagatctctacaagctcttgaagacacaacac
ctcagcaacgaccatatctgctattttctttaccagatcctcagagggttaaaatatatc
cattcagctaatgtactgcaccgtgacctcaaaccttccaacctgctgctcaacaccacc
tgtgatctcaagatctgtgactttggcttggcccgcgttgcagatccagaccatgatcac
acagggttcctgacggagtatgtagccacacgttggtaccgggctccagaaattatgttg
aattccaagggctataccaagtccattgatatttggtctgtaggctgcattctggcagag
atgctgtccaacaggcccatcttcccgggaaagcattatctcgaccagctgaaccacatt
ctgggtattcttggatccccatcacaggaagacctgaattgtataataaatttaaaagct
agaaactacttgctttctcttccacacaaaaataaggtgccatggaacaggctgttccca
aatgctgattccaaagctctggatttactggacaaaatgttgacgttcaaccctcacaag
aggattgaagtagaacaggctctggcccatccatatctggagcagtattacgacccaagt
gatgagcccgttgctgaggcaccgttcaagttcgacatggagctagacgacctgcccaag
gaaaagctcaaagagctcatcttcgaagagacggccaggttccagcccggatacaggtct
taa
Felis catus (domestic cat): 101087958
Help
Entry
101087958 CDS
T02385
Symbol
MAPK3
Name
(RefSeq) mitogen-activated protein kinase 3 isoform X2
KO
K04371
mitogen-activated protein kinase 1/3 [EC:
2.7.11.24
]
Organism
fca
Felis catus (domestic cat)
Pathway
fca01521
EGFR tyrosine kinase inhibitor resistance
fca01522
Endocrine resistance
fca01524
Platinum drug resistance
fca04010
MAPK signaling pathway
fca04012
ErbB signaling pathway
fca04014
Ras signaling pathway
fca04015
Rap1 signaling pathway
fca04022
cGMP-PKG signaling pathway
fca04024
cAMP signaling pathway
fca04062
Chemokine signaling pathway
fca04066
HIF-1 signaling pathway
fca04068
FoxO signaling pathway
fca04071
Sphingolipid signaling pathway
fca04072
Phospholipase D signaling pathway
fca04114
Oocyte meiosis
fca04140
Autophagy - animal
fca04148
Efferocytosis
fca04150
mTOR signaling pathway
fca04151
PI3K-Akt signaling pathway
fca04210
Apoptosis
fca04218
Cellular senescence
fca04261
Adrenergic signaling in cardiomyocytes
fca04270
Vascular smooth muscle contraction
fca04350
TGF-beta signaling pathway
fca04360
Axon guidance
fca04370
VEGF signaling pathway
fca04371
Apelin signaling pathway
fca04380
Osteoclast differentiation
fca04510
Focal adhesion
fca04520
Adherens junction
fca04540
Gap junction
fca04550
Signaling pathways regulating pluripotency of stem cells
fca04611
Platelet activation
fca04613
Neutrophil extracellular trap formation
fca04620
Toll-like receptor signaling pathway
fca04621
NOD-like receptor signaling pathway
fca04625
C-type lectin receptor signaling pathway
fca04650
Natural killer cell mediated cytotoxicity
fca04657
IL-17 signaling pathway
fca04658
Th1 and Th2 cell differentiation
fca04659
Th17 cell differentiation
fca04660
T cell receptor signaling pathway
fca04662
B cell receptor signaling pathway
fca04664
Fc epsilon RI signaling pathway
fca04666
Fc gamma R-mediated phagocytosis
fca04668
TNF signaling pathway
fca04713
Circadian entrainment
fca04720
Long-term potentiation
fca04722
Neurotrophin signaling pathway
fca04723
Retrograde endocannabinoid signaling
fca04724
Glutamatergic synapse
fca04725
Cholinergic synapse
fca04726
Serotonergic synapse
fca04730
Long-term depression
fca04810
Regulation of actin cytoskeleton
fca04910
Insulin signaling pathway
fca04912
GnRH signaling pathway
fca04914
Progesterone-mediated oocyte maturation
fca04915
Estrogen signaling pathway
fca04916
Melanogenesis
fca04917
Prolactin signaling pathway
fca04919
Thyroid hormone signaling pathway
fca04921
Oxytocin signaling pathway
fca04926
Relaxin signaling pathway
fca04928
Parathyroid hormone synthesis, secretion and action
fca04929
GnRH secretion
fca04930
Type II diabetes mellitus
fca04933
AGE-RAGE signaling pathway in diabetic complications
fca04934
Cushing syndrome
fca04935
Growth hormone synthesis, secretion and action
fca04960
Aldosterone-regulated sodium reabsorption
fca05010
Alzheimer disease
fca05020
Prion disease
fca05022
Pathways of neurodegeneration - multiple diseases
fca05034
Alcoholism
fca05132
Salmonella infection
fca05133
Pertussis
fca05135
Yersinia infection
fca05140
Leishmaniasis
fca05142
Chagas disease
fca05145
Toxoplasmosis
fca05152
Tuberculosis
fca05160
Hepatitis C
fca05161
Hepatitis B
fca05163
Human cytomegalovirus infection
fca05164
Influenza A
fca05165
Human papillomavirus infection
fca05166
Human T-cell leukemia virus 1 infection
fca05167
Kaposi sarcoma-associated herpesvirus infection
fca05170
Human immunodeficiency virus 1 infection
fca05171
Coronavirus disease - COVID-19
fca05200
Pathways in cancer
fca05203
Viral carcinogenesis
fca05205
Proteoglycans in cancer
fca05206
MicroRNAs in cancer
fca05207
Chemical carcinogenesis - receptor activation
fca05208
Chemical carcinogenesis - reactive oxygen species
fca05210
Colorectal cancer
fca05211
Renal cell carcinoma
fca05212
Pancreatic cancer
fca05213
Endometrial cancer
fca05214
Glioma
fca05215
Prostate cancer
fca05216
Thyroid cancer
fca05218
Melanoma
fca05219
Bladder cancer
fca05220
Chronic myeloid leukemia
fca05221
Acute myeloid leukemia
fca05223
Non-small cell lung cancer
fca05224
Breast cancer
fca05225
Hepatocellular carcinoma
fca05226
Gastric cancer
fca05230
Central carbon metabolism in cancer
fca05231
Choline metabolism in cancer
fca05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
fca05417
Lipid and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
fca00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
101087958 (MAPK3)
04012 ErbB signaling pathway
101087958 (MAPK3)
04014 Ras signaling pathway
101087958 (MAPK3)
04015 Rap1 signaling pathway
101087958 (MAPK3)
04350 TGF-beta signaling pathway
101087958 (MAPK3)
04370 VEGF signaling pathway
101087958 (MAPK3)
04371 Apelin signaling pathway
101087958 (MAPK3)
04668 TNF signaling pathway
101087958 (MAPK3)
04066 HIF-1 signaling pathway
101087958 (MAPK3)
04068 FoxO signaling pathway
101087958 (MAPK3)
04072 Phospholipase D signaling pathway
101087958 (MAPK3)
04071 Sphingolipid signaling pathway
101087958 (MAPK3)
04024 cAMP signaling pathway
101087958 (MAPK3)
04022 cGMP-PKG signaling pathway
101087958 (MAPK3)
04151 PI3K-Akt signaling pathway
101087958 (MAPK3)
04150 mTOR signaling pathway
101087958 (MAPK3)
09140 Cellular Processes
09141 Transport and catabolism
04140 Autophagy - animal
101087958 (MAPK3)
04148 Efferocytosis
101087958 (MAPK3)
09143 Cell growth and death
04114 Oocyte meiosis
101087958 (MAPK3)
04210 Apoptosis
101087958 (MAPK3)
04218 Cellular senescence
101087958 (MAPK3)
09144 Cellular community - eukaryotes
04510 Focal adhesion
101087958 (MAPK3)
04520 Adherens junction
101087958 (MAPK3)
04540 Gap junction
101087958 (MAPK3)
04550 Signaling pathways regulating pluripotency of stem cells
101087958 (MAPK3)
09142 Cell motility
04810 Regulation of actin cytoskeleton
101087958 (MAPK3)
09150 Organismal Systems
09151 Immune system
04611 Platelet activation
101087958 (MAPK3)
04613 Neutrophil extracellular trap formation
101087958 (MAPK3)
04620 Toll-like receptor signaling pathway
101087958 (MAPK3)
04621 NOD-like receptor signaling pathway
101087958 (MAPK3)
04625 C-type lectin receptor signaling pathway
101087958 (MAPK3)
04650 Natural killer cell mediated cytotoxicity
101087958 (MAPK3)
04660 T cell receptor signaling pathway
101087958 (MAPK3)
04658 Th1 and Th2 cell differentiation
101087958 (MAPK3)
04659 Th17 cell differentiation
101087958 (MAPK3)
04657 IL-17 signaling pathway
101087958 (MAPK3)
04662 B cell receptor signaling pathway
101087958 (MAPK3)
04664 Fc epsilon RI signaling pathway
101087958 (MAPK3)
04666 Fc gamma R-mediated phagocytosis
101087958 (MAPK3)
04062 Chemokine signaling pathway
101087958 (MAPK3)
09152 Endocrine system
04910 Insulin signaling pathway
101087958 (MAPK3)
04929 GnRH secretion
101087958 (MAPK3)
04912 GnRH signaling pathway
101087958 (MAPK3)
04915 Estrogen signaling pathway
101087958 (MAPK3)
04914 Progesterone-mediated oocyte maturation
101087958 (MAPK3)
04917 Prolactin signaling pathway
101087958 (MAPK3)
04921 Oxytocin signaling pathway
101087958 (MAPK3)
04926 Relaxin signaling pathway
101087958 (MAPK3)
04935 Growth hormone synthesis, secretion and action
101087958 (MAPK3)
04919 Thyroid hormone signaling pathway
101087958 (MAPK3)
04928 Parathyroid hormone synthesis, secretion and action
101087958 (MAPK3)
04916 Melanogenesis
101087958 (MAPK3)
09153 Circulatory system
04261 Adrenergic signaling in cardiomyocytes
101087958 (MAPK3)
04270 Vascular smooth muscle contraction
101087958 (MAPK3)
09155 Excretory system
04960 Aldosterone-regulated sodium reabsorption
101087958 (MAPK3)
09156 Nervous system
04724 Glutamatergic synapse
101087958 (MAPK3)
04725 Cholinergic synapse
101087958 (MAPK3)
04726 Serotonergic synapse
101087958 (MAPK3)
04720 Long-term potentiation
101087958 (MAPK3)
04730 Long-term depression
101087958 (MAPK3)
04723 Retrograde endocannabinoid signaling
101087958 (MAPK3)
04722 Neurotrophin signaling pathway
101087958 (MAPK3)
09158 Development and regeneration
04360 Axon guidance
101087958 (MAPK3)
04380 Osteoclast differentiation
101087958 (MAPK3)
09159 Environmental adaptation
04713 Circadian entrainment
101087958 (MAPK3)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
101087958 (MAPK3)
05206 MicroRNAs in cancer
101087958 (MAPK3)
05205 Proteoglycans in cancer
101087958 (MAPK3)
05207 Chemical carcinogenesis - receptor activation
101087958 (MAPK3)
05208 Chemical carcinogenesis - reactive oxygen species
101087958 (MAPK3)
05203 Viral carcinogenesis
101087958 (MAPK3)
05230 Central carbon metabolism in cancer
101087958 (MAPK3)
05231 Choline metabolism in cancer
101087958 (MAPK3)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
101087958 (MAPK3)
09162 Cancer: specific types
05210 Colorectal cancer
101087958 (MAPK3)
05212 Pancreatic cancer
101087958 (MAPK3)
05225 Hepatocellular carcinoma
101087958 (MAPK3)
05226 Gastric cancer
101087958 (MAPK3)
05214 Glioma
101087958 (MAPK3)
05216 Thyroid cancer
101087958 (MAPK3)
05221 Acute myeloid leukemia
101087958 (MAPK3)
05220 Chronic myeloid leukemia
101087958 (MAPK3)
05218 Melanoma
101087958 (MAPK3)
05211 Renal cell carcinoma
101087958 (MAPK3)
05219 Bladder cancer
101087958 (MAPK3)
05215 Prostate cancer
101087958 (MAPK3)
05213 Endometrial cancer
101087958 (MAPK3)
05224 Breast cancer
101087958 (MAPK3)
05223 Non-small cell lung cancer
101087958 (MAPK3)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
101087958 (MAPK3)
05170 Human immunodeficiency virus 1 infection
101087958 (MAPK3)
05161 Hepatitis B
101087958 (MAPK3)
05160 Hepatitis C
101087958 (MAPK3)
05171 Coronavirus disease - COVID-19
101087958 (MAPK3)
05164 Influenza A
101087958 (MAPK3)
05163 Human cytomegalovirus infection
101087958 (MAPK3)
05167 Kaposi sarcoma-associated herpesvirus infection
101087958 (MAPK3)
05165 Human papillomavirus infection
101087958 (MAPK3)
09171 Infectious disease: bacterial
05132 Salmonella infection
101087958 (MAPK3)
05135 Yersinia infection
101087958 (MAPK3)
05133 Pertussis
101087958 (MAPK3)
05152 Tuberculosis
101087958 (MAPK3)
09174 Infectious disease: parasitic
05145 Toxoplasmosis
101087958 (MAPK3)
05140 Leishmaniasis
101087958 (MAPK3)
05142 Chagas disease
101087958 (MAPK3)
09164 Neurodegenerative disease
05010 Alzheimer disease
101087958 (MAPK3)
05020 Prion disease
101087958 (MAPK3)
05022 Pathways of neurodegeneration - multiple diseases
101087958 (MAPK3)
09165 Substance dependence
05034 Alcoholism
101087958 (MAPK3)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
101087958 (MAPK3)
09167 Endocrine and metabolic disease
04930 Type II diabetes mellitus
101087958 (MAPK3)
04933 AGE-RAGE signaling pathway in diabetic complications
101087958 (MAPK3)
04934 Cushing syndrome
101087958 (MAPK3)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
101087958 (MAPK3)
01524 Platinum drug resistance
101087958 (MAPK3)
01522 Endocrine resistance
101087958 (MAPK3)
09180 Brite Hierarchies
09181 Protein families: metabolism
01001 Protein kinases [BR:
fca01001
]
101087958 (MAPK3)
09182 Protein families: genetic information processing
03036 Chromosome and associated proteins [BR:
fca03036
]
101087958 (MAPK3)
09183 Protein families: signaling and cellular processes
04147 Exosome [BR:
fca04147
]
101087958 (MAPK3)
Enzymes [BR:
fca01000
]
2. Transferases
2.7 Transferring phosphorus-containing groups
2.7.11 Protein-serine/threonine kinases
2.7.11.24 mitogen-activated protein kinase
101087958 (MAPK3)
Protein kinases [BR:
fca01001
]
Serine/threonine kinases: CMGC group
MAPK family [OT]
101087958 (MAPK3)
Chromosome and associated proteins [BR:
fca03036
]
Eukaryotic type
Centromeric chromatin formation proteins
SAC (spindle assembly checkpoint) factors
Protein kinases
101087958 (MAPK3)
Exosome [BR:
fca04147
]
Exosomal proteins
Exosomal proteins of haemopoietic cells (B-cell, T-cell, DC-cell, reticulocyte, and mast cell)
101087958 (MAPK3)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
Pkinase
PK_Tyr_Ser-Thr
ABC1
APH
Haspin_kinase
Choline_kinase
FTA2
Kdo
Motif
Other DBs
NCBI-GeneID:
101087958
NCBI-ProteinID:
XP_023102893
LinkDB
All DBs
Position
E3:complement(18396743..18402966)
Genome browser
AA seq
379 aa
AA seq
DB search
MAAAAAQGGGGGEPGGADGVGPGVSGEVEVVKGQPFDVGPRYTQLQYIGEGAYGMVSSAY
DHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRAPTLEAMRDVYI
VQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDL
KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS
NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSD
AKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFDMELDDLPKERL
KELIFQETARFQPGALEAP
NT seq
1140 nt
NT seq
+upstream
nt +downstream
nt
atggcggcggcggcggctcaggggggcgggggcggggagcccgggggagctgatggggtc
ggcccgggggtctcgggggaggtggaggtagtgaaggggcagccgttcgacgtgggcccg
cgctacacgcagctgcagtacatcggcgagggcgcgtacggcatggtcagctcagcttat
gaccacgtgcgcaagactcgcgtggccatcaagaaaatcagccccttcgagcatcagacc
tattgccagcgcacactgcgggagatccagatcttgctgcgcttccgccatgagaacgtc
attggcatccgggacattctgcgggcgcccaccctggaagccatgagggatgtctacatt
gtgcaggacctgatggagacagacctgtacaagttgctcaaaagccagcagctgagcaac
gaccacatttgctacttcctctaccagatcctgcggggcctcaagtatatccactcagcc
aacgtgctccaccgggatttaaagccctctaacctgctcatcaacaccacctgcgacctt
aagatctgtgattttggcctggcccggattgccgatcctgagcatgaccacactggcttc
ctgacagaatatgtggccacacgctggtaccgggctccagaaatcatgcttaactccaag
ggctacaccaagtccatcgacatctggtctgtgggctgcattctggctgagatgctctcc
aacaggcccatcttccctggcaagcactacctggaccagctcaaccacattctggggatc
ctgggctccccatcccaggaggacttgaattgtatcatcaacatgaaggcccgaaactac
ctacagtctctgccctccaagaccaaggtggcctgggccaagctttttcccaagtcagat
gccaaagcccttgatctgctagaccggatgttgacctttaaccccaacaaacggatcaca
gtggaggaagcactggctcacccctacctggagcagtactacgacccaacggatgagcca
gtggccgaggagcctttcaccttcgacatggagctggatgatctacccaaggagcggctg
aaggagctcatcttccaggagacagcccgcttccagcctggggcactggaggccccctaa
DBGET
integrated database retrieval system
